Antibodies to Chlamydia trachomatis and risk for tubal pregnancy.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 3177550)

Published in Am J Obstet Gynecol on October 01, 1988

Authors

M D Walters1, C A Eddy, R S Gibbs, J Schachter, A E Holden, C J Pauerstein

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio 78284-7836.

Articles by these authors

(truncated to the top 100)

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13

Chlamydial infections (third of three parts). N Engl J Med (1978) 9.21

Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89

Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet (1995) 7.46

Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64

Chlamydial infections (first of three parts). N Engl J Med (1978) 5.79

Chlamydiae. Annu Rev Microbiol (1980) 5.47

Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun (1984) 5.00

Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92

Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 4.82

Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79

Severe endemic trachoma in Tunisia. Br J Ophthalmol (1976) 4.35

Chlamydial infections. Annu Rev Med (1981) 3.94

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

Screening for chlamydial infections in women attending family planning clinics. West J Med (1983) 3.51

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44

Chlamydial infections (second of three parts). N Engl J Med (1978) 3.40

Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30

Failure of serology in diagnosing chlamydial infections of the female genital tract. J Clin Microbiol (1979) 3.27

Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19

The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid (1990) 3.08

Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis (1987) 3.02

The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med (1994) 2.92

The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA (1990) 2.91

Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA (1989) 2.87

Immunodiagnosis of sexually transmitted disease. Yale J Biol Med (1986) 2.82

The venereal nature of inclusion conjunctivitis. Am J Epidemiol (1967) 2.80

Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infection. J Clin Microbiol (1986) 2.80

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80

Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80

Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80

The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78

Lymphogranuloma venereum. II. Characterization of some recently isolated strains. J Bacteriol (1969) 2.78

Rapid diagnosis of sexually transmitted diseases--speed has a price. Diagn Microbiol Infect Dis (1986) 2.69

Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol (1991) 2.67

Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia. Am J Ophthalmol (1975) 2.66

Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65

A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55

Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 2.55

Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis (1991) 2.35

Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34

A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1991) 2.33

Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun (1988) 2.30

Cellular immunity to the mouse pneumonitis agent. J Infect Dis (1984) 2.28

Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27

Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis (1992) 2.21

Inhibition of antichlamydial IgM antibody by IgG antibody in immunofluorescence tests. J Immunol (1972) 2.20

Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis (1982) 2.17

Isolation of bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med (1966) 2.17

An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16

Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16

Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J Infect Dis (1995) 2.12

Why we need a program for the control of Chlamydia trachomatis. N Engl J Med (1989) 2.12

Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA (1993) 2.12

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12

Chlamydia trachomatis: important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr (1984) 2.11

Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol (1987) 2.11

Plaque formation by Chlamydia in L cells. Infect Immun (1970) 2.09

A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest (1993) 2.09

The intracellular life of Chlamydia. Curr Top Microbiol Immunol (1988) 2.09

Multiple-antigen slide test for detection of immunoglobulin M antibodies in newborn and infant sera by immunofluorescence. J Clin Microbiol (1981) 2.07

Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA (1986) 2.06

NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis (2000) 2.05

Enzyme immunoassay for diagnosis of gonorrhea. J Clin Microbiol (1984) 2.03

Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis (1990) 2.02

Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02

Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis (1983) 1.99

Pneumonitis following inclusion blennorrhea. J Pediatr (1975) 1.95

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first-catch urine examination. Lancet (1984) 1.91

Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med (1999) 1.91

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86

Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.84

Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol (1990) 1.83

Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr (1985) 1.81

Management of genital herpes infection in pregnancy. Obstet Gynecol (1988) 1.80

Evaluation of laboratory methods for detecting acute TRIC agent infection. Am J Ophthalmol (1970) 1.77

Antibiotic susceptibility of Chlamydia trachomatis. Antimicrob Agents Chemother (1977) 1.76

Serotyping of Chlamydia. I. Isolates of ovine origin. Infect Immun (1974) 1.76

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73

Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71

Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect Immun (1983) 1.71

Preventing neonatal herpes--current strategies. N Engl J Med (1992) 1.67

Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population. Br J Ophthalmol (1989) 1.66

Therapy of obstetrical infections with moxalactam. Antimicrob Agents Chemother (1980) 1.64

Plaque reduction technique for demonstrating neutralizing antibodies for Chlamydia. Infect Immun (1970) 1.63

Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis (1996) 1.63

Serotyping of Chlamydia: isolates of bovine origin. Infect Immun (1975) 1.61

The medical and psychosocial needs of children entering foster care. Child Abuse Negl (1987) 1.61

Immunoassay for detecting Chlamydia trachomatis major outer membrane protein. J Clin Microbiol (1983) 1.61

The etiology of nongonococcal urethritis in men attending a venereal disease clinic. Sex Transm Dis (1977) 1.60

Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis (1987) 1.59

Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun (1989) 1.58

A Bedsonia isolated from a patient with clinical lymphogranuloma venereum. Am J Ophthalmol (1967) 1.57

Role of CD8 T cells in primary Chlamydia infection. Infect Immun (1995) 1.56

Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun (1988) 1.56

Chlamydiae as agents of sexually transmitted diseases. Bull World Health Organ (1976) 1.55

Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis (1979) 1.55

Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun (1989) 1.54

Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52